Your voice might reveal mania: small study explores speech patterns
NCT ID NCT05956340
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study from Mayo Clinic looked at whether voice and speech change during manic episodes in people with bipolar I disorder. Researchers recorded interviews with 17 hospitalized participants and analyzed pitch, rhythm, grammar, and word choice. The goal was to find measurable differences that could one day help doctors spot mania more quickly.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a tool that helps doctors detect mania earlier using speech analysis.
- What could go wrong
- This is a very small, completed study (17 people) that only looked for patterns, not a treatment. The findings may not apply to everyone with bipolar disorder.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
17 people
The number who actually took part.
- Started
-
Apr 2023
- Finished
-
Sep 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Provision of informed consent before any study procedures are performed * English speaker * Documented clinical diagnosis for Bipolar I Disorder * Undergoing hospitalization, or boarding in the Emergency Department, for mania as determined by primary clinical staff Exclusion Criteria: * Positive urine drug screen for amphetamines or cocaine. * Expressing paranoid delusions regarding electronic surveillance. * Documented clinical diagnosis of developmental delay. * Currently involuntarily hospitalized. * Deemed at risk for aggression. * Failure to comprehend study objectives via comprehension questionnaire. * Individuals who have a guardian and are unable to consent for themselves. * Current communicable disease requiring isolation.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Bipolar I disorder are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic Minnesota
Rochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a nasal insulin spray rev up brain energy and sharpen thinking in psychosis?
- Could immune cells hold clues to bipolar disorder?
- Can brain implants read and treat bipolar depression without triggering mania?
- Can a 10-Hour eating window stabilize mood in bipolar disorder?
- Gold nanoparticles may make lithium therapy safer and more effective
- Can a new drug calm the storm of bipolar mania?